Market Overview:
The global computer-aided drug market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing use of computer-aided drug design (CADD) for the development of novel drugs and rising demand for personalized medicines. In addition, growing investments by pharmaceutical companies in R&D activities are also contributing to the growth of this market. Oncological disorders accounted for the largest share of the global computer-aided drug market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to increasing prevalence of cancer across the globe and growing demand for targeted therapies. Neurological disorders are projected to grow at a highest CAGR during 2018–2030 owing high unmet needs associated with various neurological diseases such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis (MS).
Product Definition:
Computer-aided drug (CAD) is a system that helps health professionals design and analyze the effects of potential drugs. It can help identify possible interactions and predict how the body will respond to a new medication.
Structure Based Drug:
Structure-based drug design is a process of designing drugs by using 3D structures as a guide. Stereochemistry plays an important role in the process. The method has its own set of advantages and disadvantages, which are different from traditional drug designing methods.
Ligand Based Drug:
Ligand-based drug design is a process of designing drugs by using synthetic or natural ligands as binding sites for the chemical moieties that are to be administered. Ligand based drug design has gained significant traction in recent years owing to its potential use in treating diseases caused by unbalanced receptor activity such as oncology, metabolic disorders, and immunological disorders.
Application Insights:
Oncological disorders accounted for the largest share in 2015 owing to increasing prevalence of cancer and rising death rate due to cancer. The other application segment includes infectious diseases, cardiovascular disorders, respiratory disorders, gastrointestinal disorders and urological disorder. Increasing prevalence of chronic conditions such as diabetes mellitus, which increases the risk of death caused by various causes including heart disease & stroke and liver disease is anticipated to boost demand for computers-aided drugs over the forecast period.
The growing adoption of structure based drug design in target identification coupled with high success rates achieved through this approach is expected to drive growth from 2016 to 2030AD market growth. In addition structure based drug design helps identify potential adverse effects before clinical trials even start thus are being increasingly adopted across all therapeutic areas thereby contributing towards overall market growth during same period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of global players, increased adoption of novel technologies and high healthcare expenditure in this region. Moreover, increasing government funding for R&D activities pertaining to CNS disorders is also expected to boost growth during the forecast period. Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income levels and improving economic conditions in emerging countries such as China and India. Furthermore, these factors are contributing toward rapid expansion of manufacturing facilities by major companies operating within this region which further boosts regional market development.
The key companies present within this space include Merck KGaA; Pfizer Inc.; Allergan PLC; sanofi; Bayer AG & Co.
Growth Factors:
- Increasing demand for better and faster drugs to cure various diseases
- Rising prevalence of chronic diseases that require long-term treatment
- Growing number of clinical trials and research studies to develop new drugs
- Technological advancements in the field of computer-aided drug design and development
- Increasing investments by pharmaceutical companies in R&D activities
Scope Of The Report
Report Attributes
Report Details
Report Title
Computer-Aided Drug Market Research Report
By Type
Structure Based Drug, Ligand Based Drug
By Application
Oncological Disorders, Neurological Disorders, Other
By Companies
Market Positioning Of Vendors, Aaranya Biosciences Pvt. Ltd., Albany Molecular Research Inc., Charles River Laboratories International Inc., Chembio Discovery Inc., Chemical Computing Group ULC, Compchem Solutions Ltd., International Business Machines Corp., Kang Yusheng Information Technology Co. Ltd., Openeye Scientific Software Inc., Pharmaron Beijing Co. Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Computer-Aided Drug Market Report Segments:
The global Computer-Aided Drug market is segmented on the basis of:
Types
Structure Based Drug, Ligand Based Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncological Disorders, Neurological Disorders, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Market Positioning Of Vendors
- Aaranya Biosciences Pvt. Ltd.
- Albany Molecular Research Inc.
- Charles River Laboratories International Inc.
- Chembio Discovery Inc.
- Chemical Computing Group ULC
- Compchem Solutions Ltd.
- International Business Machines Corp.
- Kang Yusheng Information Technology Co. Ltd.
- Openeye Scientific Software Inc.
- Pharmaron Beijing Co. Ltd.
Highlights of The Computer-Aided Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Structure Based Drug
- Ligand Based Drug
- By Application:
- Oncological Disorders
- Neurological Disorders
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Computer-Aided Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Computer-aided drug design (CAD) is a process of designing drugs using computer models. CAD allows scientists to explore different drug combinations and designs more quickly and efficiently than traditional methods.
Some of the major companies in the computer-aided drug market are Market Positioning Of Vendors, Aaranya Biosciences Pvt. Ltd., Albany Molecular Research Inc., Charles River Laboratories International Inc., Chembio Discovery Inc., Chemical Computing Group ULC, Compchem Solutions Ltd., International Business Machines Corp., Kang Yusheng Information Technology Co. Ltd., Openeye Scientific Software Inc., Pharmaron Beijing Co. Ltd..
The computer-aided drug market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Computer-Aided Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Computer-Aided Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Computer-Aided Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Computer-Aided Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Computer-Aided Drug Market Size & Forecast, 2018-2028
4.5.1 Computer-Aided Drug Market Size and Y-o-Y Growth
4.5.2 Computer-Aided Drug Market Absolute $ Opportunity
Chapter 5 Global Computer-Aided Drug Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Computer-Aided Drug Market Size Forecast by Type
5.2.1 Structure Based Drug
5.2.2 Ligand Based Drug
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Computer-Aided Drug Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Computer-Aided Drug Market Size Forecast by Applications
6.2.1 Oncological Disorders
6.2.2 Neurological Disorders
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Computer-Aided Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Computer-Aided Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Computer-Aided Drug Analysis and Forecast
9.1 Introduction
9.2 North America Computer-Aided Drug Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Computer-Aided Drug Market Size Forecast by Type
9.6.1 Structure Based Drug
9.6.2 Ligand Based Drug
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Computer-Aided Drug Market Size Forecast by Applications
9.10.1 Oncological Disorders
9.10.2 Neurological Disorders
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Computer-Aided Drug Analysis and Forecast
10.1 Introduction
10.2 Europe Computer-Aided Drug Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Computer-Aided Drug Market Size Forecast by Type
10.6.1 Structure Based Drug
10.6.2 Ligand Based Drug
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Computer-Aided Drug Market Size Forecast by Applications
10.10.1 Oncological Disorders
10.10.2 Neurological Disorders
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Computer-Aided Drug Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Computer-Aided Drug Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Computer-Aided Drug Market Size Forecast by Type
11.6.1 Structure Based Drug
11.6.2 Ligand Based Drug
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Computer-Aided Drug Market Size Forecast by Applications
11.10.1 Oncological Disorders
11.10.2 Neurological Disorders
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Computer-Aided Drug Analysis and Forecast
12.1 Introduction
12.2 Latin America Computer-Aided Drug Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Computer-Aided Drug Market Size Forecast by Type
12.6.1 Structure Based Drug
12.6.2 Ligand Based Drug
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Computer-Aided Drug Market Size Forecast by Applications
12.10.1 Oncological Disorders
12.10.2 Neurological Disorders
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Computer-Aided Drug Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Computer-Aided Drug Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Computer-Aided Drug Market Size Forecast by Type
13.6.1 Structure Based Drug
13.6.2 Ligand Based Drug
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Computer-Aided Drug Market Size Forecast by Applications
13.10.1 Oncological Disorders
13.10.2 Neurological Disorders
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Computer-Aided Drug Market: Competitive Dashboard
14.2 Global Computer-Aided Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Market Positioning Of Vendors
14.3.2 Aaranya Biosciences Pvt. Ltd.
14.3.3 Albany Molecular Research Inc.
14.3.4 Charles River Laboratories International Inc.
14.3.5 Chembio Discovery Inc.
14.3.6 Chemical Computing Group ULC
14.3.7 Compchem Solutions Ltd.
14.3.8 International Business Machines Corp.
14.3.9 Kang Yusheng Information Technology Co. Ltd.
14.3.10 Openeye Scientific Software Inc.
14.3.11 Pharmaron Beijing Co. Ltd.
